DermTech, Inc. , a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the appointment of Bret Christensen, previously chief commercial officer of. | May 9, 2023
Structured to Accelerate Innovation and Commercialization PrioritiesCreates New Roles to Oversee Product & End-to-End Customer Experience and TechnologyACTON, Mass. (BUSINESS WIRE) Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® b.
Acton-based diabetes equipment manufacturer Insulet has reorganized its executive structure amid a 21% gain in first-quarter revenue. Jim Hollingshead will continue to lead the company as president and CEO.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.